Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA adds boxed warning to Pfizer’s Xeljanz drug in ulcerative colitis

pharmaceutical-technologyJuly 30, 2019

Tag: FDA , Pfizer , ulcerative colitis

PharmaSources Customer Service